Cancer care quality perception among cancer survivors: Impact of provider time spent and shared decision making.
Abstract
e23158 Background: This study evaluates cancer survivors’ perception of their cancer care quality, as well as the factors that predict cancer care quality perception. Methods: Study data was derived from the HINTS-SEER 2021 pilot study, a survey of 1,210 cancer survivors from three SEER cancer registries. Sociodemographic and clinical characteristics of cancer survivors was described and stratified by their perception of their cancer care quality. Multivariable logistic regressions were used to examine for factors that impact perception of cancer care quality among cancer survivors. Results: Overall, almost 70% of cancer survivors described their cancer care quality as excellent. Excellent care was predominantly reported among Non-Hispanic White, postgraduates, urban residents, respondents without cancer treatment-related toxicity and those earning ≥ $75,000. A significant proportion of survivors who reported that their healthcare provider always spent adequate time with them perceived their cancer care as excellent (81.2%) compared to reports other than always (57.3%) (p < 0.001). Similarly, survivors who were always involved in shared decision-making reported excellent cancer care quality to greater degree (80.0%) compared to those who were not always involved (53.8%) (p < 0.001). Logistic regression models revealed that both adequate time spent (OR = 3.23, 95% CI = 2.14–4.86, p < 0.001) and shared decision-making (OR = 3.06, 95% CI = 2.06–4.54, p < 0.001) were significant predictors of perceiving excellent cancer care quality, after controlling for cancer treatment related toxicities, stage of treatment/time from cancer directed treatment, and sociodemographic characteristics of survivors. Conclusions: Results suggest that improving time allocation with providers and fostering shared decision-making could help enhance the perceived quality of care among cancer survivors.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (4)
Onyema Chido-Amajuoyi
University of Washington/Fred Hutchinson Cancer Center, Seattle, WA
Henry Onyeaka
Massachusetts General Hospital, Boston, MA
Crystal Okpagu
American University of Antigua, Antigua, Antigua and Barbuda
Sanjay Shete